The Belgium Financial Services and Markets Authority suspended trading in Celyad Oncology financial instruments (ISIN BE0974260896) on Euronext Brussels from 11 February 2026 at 14:35 CET until the publication of a press release.
Belgium Financial Services and Markets Authority 2026-02-11
Belgium Financial Services and Markets Authority suspends trading in Celyad Oncology on Euronext Brussels until a press release is published
The Belgium Financial Services and Markets Authority suspended trading in Celyad Oncology financial instruments on Euronext Brussels from 11 February 2026 at 14:35 CET pending a press release.